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A Microcystic Adnexal Carcinoma in the Auditory Canal 
15 Years after Radiotherapy of a 12-Year-Old Boy with 
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Background: Radiogenic malignancies require cure of the primary disease and a prolonged survival. The introduction of high-volt 
technology in the 1950s and 1960s made radical radiotherapy feasible and successful in terms of higher cure rates and longer 
survival. We are already in a time when a higher number of patients with radiogenic secondary malignancies must be expected.
Case Report: A 12-year-old boy is reported who suffered from an advanced nasopharynx carcinoma and was treated with radical 
irradiation in 1983. 15 years later he developed a rare microcystic adnexal carcinoma of the auditory canal inside the volume of 
the target dose. The secondary malignant neoplasm was resected and required another radiation treatment (1 Gy b.i.d.) due to 
involved margins.
Discussion and Literature Review: The entity of microcystic carcinoma is discussed with a review of the literature on biology, 
diagnosis, and treatment.
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Mikrozystisches adnexales Karzinom des äußeren Gehörgangs 15 Jahre nach Radiotherapie eines 12-jährigen Patienten 
mit Nasopharynxkarzinom  
Hintergrund: Radiogene Zweittumoren setzen Heilung der Ersterkrankung und langes Überleben voraus. Nach Einführung der 
Hochvolt-Strahlentherapie in den 50er und 60er Jahren wurden durch kurative Strahlentherapie höhere Heilungsraten und ver-
längertes Überleben ermöglicht. Wir kommen zu oder sind bereits in einer Zeit, in der mit erhöhter Wahrscheinlichkeit mit dem 
Auftreten radiogener Zweittumoren gerechnet werden muss.
Fallbericht: Berichtet wird über einen Patienten, der 1983 als 12-Jähriger wegen eines lokoregionär fortgeschrittenen Naso-
pharynxkarzinoms kurativ bestrahlt wurde und bei dem 15 Jahre später ein sehr seltenes mikrozystisches adnexales Karzinom 
des äußeren Gehörgangs im Volumen der Zieldosis diagnostiziert wurde. Die Zweitneoplasie wurde operiert und erforderte wegen 
R1-Resektion eine postoperative Radiotherapie (1 Gy b.i.d.).
Diskussion und Literaturübersicht: Die Entität des mikrozystischen Karzinoms wird mit einer Literaturübersicht in Bezug auf 
Biologie, Diagnose und Therapie diskutiert.
Schlüsselwörter:  Radiogenes Zweitkarzinom · Pädiatrisches Nasopharynxkarzinom · Mikrozystisches Karzinom · Zweit-
bestrahlung
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Introduction 
Parallel to the technical development radical radiotherapy be-
came more successful with the result of cure and longer sur-
vival time. Cure from the first malignancy and long survival 
are the preconditions for the development of a radiogenic sec-
ondary malignant neoplasm. Due to their longer life expec-
tancy and their still growing organs children are particularly at 
risk [8, 15, 25, 27, 31, 33, 36, 38, 40, 42, 45, 46, 57, 59]. As one of 
the most serious late sequelae of radiotherapy, secondary ma-
lignancies can develop after a long latent period [4, 10, 20]. 
Most literature is about secondary malignant neoplasms in 
Hodgkin’s disease and brain tumors.
Nasopharynx carcinoma (NPC) in children is rare [6, 35, 
58] and often develops as a painless cervical swelling of en-
larged, sometimes huge cervical lymph nodes. Epstein-Barr 
virus (EBV) infection is a known risk factor [41]. The 5-year 
overall survival rates are about 58% [3]. The prognosis in chil-
dren is independent of gender and race [35, 43]. Distant me-
tastases can develop in up to 40% of patients [2, 19, 43, 44, 48]. 
The current standard treatment of NPC in children is simulta-
neous radiochemotherapy [5, 14, 24, 53, 61].
We would like to report on a secondary malignancy 15 
years after radical exclusive radiotherapy in a 12-year-old boy, 
who suffered from an advanced NPC. Written informed con-
sent was obtained from the patient. 
Case Report 
Nasopharynx Carcinoma (NPC) 
In 1983, a 12-year-old boy in good health and with an unre-
markable personal history was sent to radiotherapy for a lo-
coregionally advanced undifferentiated NPC, then called type 
Schmincke-Regaud. He presented with bilateral huge cervical 
lymph nodes. The CT demonstrated the primary tumor in the 
nasopharynx which reached far into the nasal cavity and into 
the oropharynx. Infiltration of the base of skull was confirmed 
by bone scintigraphy. The TNM category was cT3cN2M0 
(UICC 1998).
Methods of radiotherapy for NPC. The portals were docu-
mented by simulation. Cobalt-60 (60Co) photons were used for 
treatment. Lateral opposed fields included the base of skull 
and the regional levels II, III, and V. For level IV anteroposte-
rior-posteroanterior (AP-PA) portals were used (Figure 1). 
For the phase after 39.6 Gy the portals for the primary tumor 
and cervical lymph nodes were split in order to spare the spi-
nal cord. The fields were reduced posteriorly and supplement-
ed by 9-MeV electron fields. In the supraclavicular regions 
midline blocks were used after 39.6 Gy for spinal cord sparing. 
A total dose of 59.4 Gy on the 90% isodose was given for the 
primary tumor and the cervical lymph nodes, single dose was 
1.8 Gy. The supraclavicular region was irradiated to a total 
dose of 59.4 Gy on the ipsilateral left side and 50.4 Gy on the 
contralateral right side. The outer auditory canal was always 
included in the volume for the primary tumor and received a 
dose of 66.6 Gy. No concomitant chemotherapy was given. A 
skin reaction grade 2 and a mucositis grade 3 developed.
Late effects of first radiotherapy. The NPC had remained in 
complete remission to date. The oral mucosa became atrophic 
and the patient lost his teeth as a consequence of xerostomia 
but did not suffer from severe side effects at first [17, 22, 23]. 
However, beginning in the 5th year after radiotherapy the 
then 17-year-old boy became symptomatic from diverse se-
vere and clinically evident late effects.
As the first symptom a left phrenicus paresis appeared. 1 
year later a paresis of the right N. V with dyskinesias occurred, 
and again 1 year later a right partial conduction deafness was 
diagnosed. At that time a hypoplasia of the ossicular chain 
bones and a marked atherosclerosis in both carotid arteries 
were shown on the CT scan. In the 8th year of follow-up an 
arterial hypertension was found. Meanwhile, the cervical spine 
had become heavily deformed (Figure 2), the right mandible 
hypotrophic and all cervical soft tissues atrophic.
In the 10th year after radiotherapy the meanwhile 
22-year-old patient suffered from a thrombosis of the left jug-
ular vein and the left brachiocephalic vein, and a collateral 
circulation in the upper thoracic aperture had developed (Fig-
ure 2). In both carotid arteries marked atherosclerosis was 
found [9, 50], and the patient was anticoagulated for the next 
5 years.
Figure 1. Lateral opposed simulator films of the first radiotherapy for 
nasopharynx carcinoma show the inclusion of the external auditory 
canal in the high-dose irradiation volume. 
Abbildung 1. Seitlich opponierende Simulatoraufnahme der ersten 
Radiotherapie des Nasopharynxkarzinoms zeigen den Einschluss des 
äußeren Gehörganges in das Hochdosisvolumen.  
Beer KT, et al. Radiogenic Malignancy in a Boy with NPC
407Strahlenther Onkol 2005 · No. 6  © Urban & Vogel
The radiotherapy had also caused endocrinological alter-
ations, which were clinically not significant and were diag-
nosed only at the time when preparation for postoperative 
radiotherapy of the secondary malignant neoplasm was orga-
nized. Basal TSH (thyroid-stimulating hormone) was signifi-
cantly increased to 12.7 mU/l (normal range, 0.35–4.5 mU/l) 
with an FT3 (free triiodothyronine) of 4.84 pmol/l (normal 
range, 3.5–6.5 pmol/l) and an FT4 (free thyroxine) of 
10.7 pmol/l, (normal range, 9.5–25 pmol/l). The TRH (thyro-
tropin-releasing hormone) profile showed a normal TSH re-
sponse but an insufficient increase during the night. On so-
nography a small, hypotrophic thyroid gland with regressive 
alterations in both lobules was found, a further late side ef-
fect of radiotherapy. Those findings are indicative of a pri-
mary hypothyreosis and a small component of a secondary 
hypothyreosis caused by irradiation of the pituitary gland. A 
substitution with levothyroxine was initiated. The sex hor-
mones showed the following baseline values: LH (luteinizing 
hormone) 10.8 U/l (normal range, 3–16 U/l), FSH (folli-
cle-stimulating hormone) 24.9 U/l (normal range, 2–9 U/l), 
and testosterone 94.8 pmol/l (normal range, 66–142 pmol/l). 
Decreased stimulation indicated a dysfunction of Leydig 
cells. Caryotyping ruled out a Klinefelter syndrom, whereas 
alcohol abuse was considered the probable cause. The 
ACTH-cortisol axis and the growth hormone production 
were not involved.
13 years after treatment, a chronic eczema of the right ex-
ternal auditory canal was diagnosed for the first time, presum-
ably the first hint at the later diagnosed secondary malignant 
neoplasm.
Microcystic Adnexal Carcinoma (MAC)
Diagnosis. In December 1998, 15 years after radiotherapy of 
the NPC, the meanwhile 28-year-old patient contacted his 
family practitioner because of increased pain in the right ear 
and progressive hearing loss. On clinical examination the right 
pinna was painful to touch and scaling crusts were found in the 
external auditory canal. A CT scan of the base of skull demon-
strated a soft-tissue mass in the right external acoustic meatus 
extending to the right pyramid, and on the MRI scan a circu-
lar, contrast-enhancing infiltrating mass around the auditory 
canal was seen; suspect lymph nodes were not found. The first 
biopsy was diagnosed as a moderately differentiated squa-
mous cell carcinoma.
Surgery. An extended lateral parotidectomy and a modified 
radical neck dissection of the levels II–IV were performed. 
The defect was closed with a flap of the pectoralis major mus-
cle. The external auditory canal was reconstructed with a sili-
cone catheter and a Thiersch graft. On the postoperative CT 
no macroscopic tumor rest was seen. The definitive histopath-
ologic diagnosis described a typical MAC. The tumor showed 
a dissociated and infiltrating growth especially of the perineu-
ral sheaths, a focal squamous differentiation, and pseudoepi-
theliomatous hyperplasia (Figure 3). 18 lymph nodes were 
free of metastases, but the carcinoma reached the resection 
margins (R1 resection). Concerning the former radiotherapy, 
significant alterations were seen in the dermis and the under-
lying layers. Because of the incomplete resection and the his-
tological aggressiveness we decided for a second radical radio-
therapy.
Figure 2. Musculoskeletal changes (atrophy of erector trunci muscles, 
kyphoscoliosis of the cervical spine), marked telangectasias in the pre-
viously irradiated regions, and extensive collateral circulation in the 
left thoracic aperture. 
Abbildung 2. Muskuloskelettale Veränderungen (Atrophie des Erector 
trunci, Kyphoskoliose der HWS), deutliche Teleangiektasien der be-
strahlten Regionen und ausgedehnter Kollateralkreislauf der linken 
Thoraxapertur.  
Figure 3. Histological specimen showing a typical microcystic adnexal 
skin carcinoma with extended dissociated and infiltrating growth, in-
filtration of perineural sheaths, focal squamous differentiation, and 
pseudoepitheliomatous hyperplasia, HE 25×. 
Abbildung 3. Histologisches Präparat eines typischen mikrozystisch 
adnexalen Hautkarzinoms mit ausgedehntem dissoziierten und in-
filtrierenden Wachstum, Infiltration von Perineuralscheiden, fokal 
squamöser Differenzierung und pseudoepitheliomatöser Hyperpla-
sie, HE 25×.  
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Radiotherapy for MAC. At referral for the second radio-
therapy, the patient had a Karnofsky index of 90. His height 
was 163 cm (normal height in comparison with his siblings) 
and his weight 60 kg. Blood pressure under medication was 
120/80 mmHg. The flap in the right parotid region was healed, 
the patient had no immediate postoperative symptoms. Sali-
va production was reduced (unstimulated saliva flow 0.24 ml/
min; stimulated 0.44 ml/min) and, as a consequence, the pa-
tient was edentulous.
As our standard treatment for a second course of radical 
irradiation after a first full-course radiotherapy, we employed 
a 3-D-based bifractionated (1 Gy b.i.d.) regimen and applied a 
total dose of 66 Gy in the ICRU point. The clinical target vol-
ume (CTV) encompassed the former tumor region of the re-
sected auditory canal and the first lymphatic drainage to the 
parotid and the level II area. An isocentric application tech-
nique at the linear accelerator was used with convergent fields 
of 6-MV photons (Figure 4).
Radiotherapy was not combined with simultaneous che-
motherapy which does not seem effective for MAC.
The second radiation treatment was surprisingly well tol-
erated; acute skin and mucosal reactions did never exceed 
grade 2 and disappeared within 6 weeks.
The patient was last seen 66 months after the second ra-
diotherapy. He was in a good performance status. The tumor 
remained in complete clinical and radiologic remission. The 
patient reported occasional slight pain when opening his 
mouth which was already reduced after the first treatment, 
and discharge from the surgical scar. The last follow-up CT 
scan showed a complete remission, a fibrosis of the temporo-
mandibular joint, and a streaky imbuement of the fatty tissues 
of the flap (Figure 5).
The most recent laboratory parameters included a macro-
cystic anemia (hemoglobin 105 g/l) probably as a consequence 
of chronic alcohol abuse. The substitution with levothyroxine 
was successful with a suppression of the basal TSH level to 
0.003 and an increase in FT3 and FT4 to 6 and 24.2 pmol/l, re-
spectively.
Discussion
We report on a rare case of MAC in the auditory canal that 
developed 15 years after radical radiotherapy for an NPC in a 
then 12-year-old boy, who was a second time successfully 
treated by subradical surgery and postoperative irradiation.
Since NPC in children is a rare disease, few data on sec-
ondary tumors after radiotherapy of NPC in children are 
found.
MAC was first defined in 1982 by Goldstein et al. [21]. In 
the literature mostly case reports are described [7, 30, 39, 47, 
Figure 4. 3-D-planned dose distribution of convergent fields with de-
lineation of planning target volume.
Abbildung 4. 3-D geplante Dosisverteilung mittels konvergierender 
Felder und Darstellung des PTV. 
Figure 5. CT scan showing complete remission of the tumor with post-
radiotherapeutic alterations in the flap tissue and marked atheroscle-
rotic lesions in the carotid arteries. 
Abbildung 5. CT mit kompletter Remission des Tumors, post-radioge-
nen Veränderungen im Lappengewebe und deutlicher Atherosklerose 
in den Karotiden.  
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49], but never as a secondary malignant neoplasm after radio-
therapy for NPC.
In a larger series of 27 patients, Antley et al. [1] showed 
most tumors to be second carcinomas after a radical radio-
therapy. The carcinomas developed up to 30–40 years after 
irradiation. Preferred localizations were centrofacial and cer-
vical regions; involvement of the ear is only reported twice 
[11, 28]. 
At clinical examination most often asymptomatic slowly 
growing nodules or cyst-like tumors are found, some present-
ing with a scar-like appearance [7, 10]. The tumor can be mis-
taken for other neoplasms, such as squamous cell carcinoma 
[7, 12, 13, 21] as in the first biopsy of our patient. There is a 
relationship of MAC with salivary and sweat gland tumors 
[60], since they share common histological features and chro-
mosomal aberrations.
The MACs are locally invasive, destructive, and often in-
filtrate perineural sheaths [7]. It is difficult to obtain clean 
margins, as these tumors can spread far beyond the visible le-
sion [12]. They have a high recurrence rate; hematogenous 
metastases are rare [7, 20]. Surgery is recommended as the 
treatment of choice [12, 18], particularly Moh’s microsurgery.
A gross tumor mass of MAC is commonly considered to 
be radioresistant [49]. A sequential treatment strategy of re-
section and radiotherapy is rational. For microscopic residual 
tumor the indication for radiotherapy is clearly given. This ap-
proach was validated in our case, in which the concept of a 
second radical radiotherapy 15 years after the first radical 
treatment was chosen instead of a further mutilating surgery 
followed by adjuvant radiotherapy [16, 26, 29, 32, 34, 37, 
51–56]. The risk paid off, the patient is now 6 years in a com-
plete remission and has no additional serious side effects after 
the second radiation treatment regimen.
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